Several studies have demonstrated that C-reactive protein [4, 5], B-type natriuretic peptide (NT-pro-BNP) [6], and serum cardiac troponin I (cTN-I) [7] as robust serum biomarkers for CAD risk. This evidence concerns the gene TNNI3 and coronary artery disorder.